Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reprogramming urokinase into an antibody-recruiting anticancer agent

Reprogramming urokinase into an antibody-recruiting anticancer agent

US Patent 12312621 · Granted May 27, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bifunctional small molecules to target the selective degradation of circulating 2025
Bifunctional small molecules to target the selective degradation of circulating 2025
Molecular degraders of extracellular proteins2025
Therapeutic DNP derivatives and methods using same2024
CD16a binding agents and uses thereof2024
Molecular degraders of extracellular proteins2024
Bi-functional molecules to degrade circulating proteins2024
Chimeric small molecules for the recruitment of antibodies to cancer cells2024
Decarboxylated cannabis compositions and methods of making the same2024
Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prosta2024
Reprogramming urokinase into an antibody-recruiting anticancer agent2024
Reprogramming urokinase into an antibody-recruiting anticancer agent2024